Skylar is an associate editor for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®, and joined AJMC® in 2020. She is responsible for covering all aspects of the ever-changing global biosimilar industry and produces content that is accessible and informative for all health care stakeholders.
She has a BA in journalism and media studies from Rutgers University. You can connect with Skylar on LinkedIn.
Fully Vaccinated Patients With MM at Greater Risk for Breakthrough COVID-19 Infection
February 8th 2022Patients with multiple myeloma (MM) who have been fully vaccinated against COVID-19 were found to have an increased risk of breakthrough infections and related hospitalizations, signaling the need for more studies and precautions.
Read More
Which Factors Sway Patient, Caregiver Decisions About CKD Research Participation?
February 7th 2022Patients with chronic kidney disease (CKD) and their caregivers who have participated in CKD research shared factors that may encourage or discourage others from enrolling in clinical studies, highlighting the ways that investigators can better involve patients in research.
Read More
Dr Robert Gabbay Explains the Development of the ADA's New CKD Guidelines
February 4th 2022Robert Gabbay, MD, PhD, of the American Diabetes Association (ADA), discusses the development process for the section of ADA guidelines that touches on chronic kidney disease (CKD) management in patients with diabetes.
Read More
COVID-19 Led to Delayed Diagnoses, Increased Infection Risk, Lower Survival Rates in MM
February 1st 2022A large international real-world analysis revealed the extent to which the COVID-19 pandemic has impacted the global population of patients with multiple myeloma (MM) and the ability for providers to help patients manage the condition.
Read More
Study: Adrenal Insufficiency Found in Some MM Patients on Corticosteroid-Based Chemotherapy
January 28th 2022About half of all patients with multiple myeloma (MM) receiving corticosteroid-based chemotherapy were found to have adrenal insufficiency (AI), while identifying suspicious symptoms of AI may be a key component to its detection in this population.
Read More
New Section on Chronic Kidney Disease Risk Management Added to ADA Standard of Care Guidelines
January 27th 2022The American Diabetes Association (ADA) has added a new section to their 2022 Standard of Care guidelines to assist clinicians in managing and preventing the presence of chronic kidney disease and related complications in patients with diabetes.
Read More
Study Supports Pfizer, Moderna COVID-19 Vaccines’ Safety in Patients With Multiple Myeloma
January 26th 2022Study results showed that both the Pfizer-BioNTech and Moderna COVID-19 vaccines were safe and effective in patients with multiple myeloma, which investigators hope will improve vaccine hesitancy in the high-risk population.
Read More
Panelists Explore What Exactly Is Holding Up US Adoption of Biosimilars
January 26th 2022Payer intervention, lack of patient savings, and confusion surrounding interchangeability are some of the many barriers standing in the way of US biosimilar uptake, with our group of panelists calling for big changes.
Read More
Gender Differences for Health-Related QOL Detected Among Patients With Advanced Kidney Disease
January 24th 2022Although men and women with advanced kidney disease experienced physical and mental declines in health-related quality of life (QOL), men’s declines occurred at a significantly faster rate, researchers concluded.
Read More
Patents Filed a Decade Post Originator Approval Account for Most Biosimilar Patent Lawsuits
January 21st 2022Researchers have found that most US patent infringement cases against biosimilar manufacturers cover patents filed over a decade after the originator product's FDA approval, leading to limits on competition among biologic drugs.
Read More
Study: Which AI Model Is the Best at Detecting Early-Stage CKD?
January 19th 2022A study comparing 4 different artificial intelligence (AI) models found that some models were better than others at detecting early-stage chronic kidney disease (CKD), when patients do not experience visible symptoms.
Read More
Different Pathogeneses May Cause Dementia in Older, Younger Patients With PD
January 15th 2022Older patients with Parkinson disease (PD) were found to have a higher incidence of dementia compared with younger patients. However, the difference may have to do with different pathologies causing dementia in older and younger patients.
Read More
Ophthalmology Biobetters and Biosimilars May Be Just Around the Corner
January 12th 2022More biobetter drugs may be on the horizon, with an opportunity to snatch market share from reference products, and several biosimilars are under development for ophthalmic conditions, authors of a review concluded.
Read More
How Does CGP Testing Align With Recommendations, Impact Budgets?
January 10th 2022Posters from the Academy of Managed Care Pharmacy Nexus 2021 meeting detailed how coverage of genetic testing aligns with current guidelines as well as the potential budget impact of expanding access to comprehensive genomic profiling (CGP).
Read More
Apixaban Cuts Recurrent Venous Thromboembolism Risk in CKD Better Than Warfarin
January 9th 2022Risk of recurrent venous thromboembolism (VTE) in patients with chronic kidney disease (CKD) and VTE was significantly reduced in those who were treated with apixaban vs warfarin, investigators concluded.
Read More
Active Video Games Improve Balance Better Than Conventional Rehab in MS
January 7th 2022Video games that involve physical exertion was found to be more effective at improving balance in patients with multiple sclerosis (MS) compared with more conventional rehabilitation methods, investigators concluded.
Read More
Review: Greater Focus on Targeting Insulin Resistance in Patients With CKD May Be Needed
January 7th 2022Insulin resistance may become a future target of treatment in the chronic kidney disease (CKD) population because of the several mechanisms in patients that contribute to increasing resistance, authors of a review concluded.
Read More
Focus Group Expresses Needs, Wants for a Mobile CKD Management App
December 30th 2021A focus group consisting of patients with chronic kidney disease (CKD) as well as CKD providers and researchers shared what they deem necessary and helpful to include in future mobile CKD management applications.
Read More